依替米星+美罗培南对多药耐药铜绿假单胞菌肺部感染的治疗分析  

Analysis of etilmicin combined with meropenem in the treatment of pulmonary infection caused by multidrug resistant pseudomonas aeruginosa

作　　者：周丽华 Zhou Lihua(The 983rd Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army,Tianjin 300142)

机构地区：[1]中国人民解放军联勤保障部队第九八三医院,天津300142

出　　处：《中国社区医师》2021年第12期69-70,共2页Chinese Community Doctors

摘　　要：目的:分析依替米星+美罗培南对多药耐药铜绿假单胞菌肺部感染的治疗效果。方法:2017年9月-2019年9月收治多药耐药铜绿假单胞菌肺部感染患者66例,随机分为两组,各33例。对照组采用依替米星治疗,观察组采用依替米星联合美罗培南治疗,比较两组治疗效果。结果:观察组体温、WBC、PCT、CRP水平低于对照组,PaO_(2)/FiO_(2)水平高于对照组,差异有统计学意义(P<0.05)。结论:依替米星+美罗培南对多药耐药铜绿假单胞菌肺部感染的治疗效果显著,不仅能改善临床指标水平,还能降低炎性因子水平。Objective:To analyze the therapeutic effect of etilmicin combined with meropenem in the treatment of pulmonary infection of multidrug resistant pseudomonas aeruginosa.Methods:From September 2017 to September 2019,66 patients with pulmonary infection caused by multidrug resistant pseudomonas aeruginosa were selected,they were randomly divided into the two groups with 33 cases in each group.The control group was treated with etilmicin.The observation group was treated with etilmicin combined with meropenem.The therapeutic effects of the two groups were compared.Results:The levels of body temperature,WBC,PCT and CRP in the observation group were lower than those in the control group,while the level of PaO_(2)/FiO_(2) was higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Etilmicin combined with meropenem is effective in the treatment of pulmonary infection caused by multidrug resistant pseudomonas aeruginosa,which can not only improve the clinical index,but also reduce the level of inflammatory factors.

关 键 词：依替米星 美罗培南 多药耐药铜绿假单胞菌肺部感染 治疗效果 

分 类 号：R563.1[医药卫生—呼吸系统]